Moderna's Spikevax becomes the first UK-made mRNA vaccine
Moderna's Spikevax becomes the first UK-made mRNA vaccine
- The UK's MHRA has approved Moderna’s Covid-19 Spikevax for the NHS vaccine campaign this year.
- The vaccine will be manufactured at the Moderna Innovation and Technology Centre in Oxfordshire, which has the potential to produce up to 250 million doses in a pandemic.
- The approval signifies a collaboration aimed at enhancing the UK's pandemic preparedness and building a sustainable vaccine supply chain.
Story
insight shift policy trends geopolitical insight analysis analysis geopolitical analysis strategic strategic insight strategic geopolitical economic shift insight analysis economic trends insight impact analysis impact data strategic analysis shift analysis insight economic data data global impact insight market impact shift analysis trends geopolitical insight data data impact global data trends economic strategic market policy geopolitical shift data policy analysis policy shift market global strategic policy strategic shift impact geopolitical trends insight economic data trends insight geopolitical policy strategic trends global...
Context
market market insight policy impact data shift strategic impact market global data policy market data insight shift impact insight geopolitical analysis policy impact policy trends analysis economic trends market policy market trends market geopolitical trends policy analysis economic impact global market impact policy trends geopolitical insight impact market analysis trends trends market trends strategic geopolitical policy impact market geopolitical analysis economic strategic policy global insight impact shift policy market strategic strategic global global trends market global shift geopolitical impact geopolitical...
